anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

216,781-216,840 of 319,975

filter-aware
26
Includes detailed footnotes explaining adjustments and share repurchase program details.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
27
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
28
Includes detailed footnotes regarding fund exclusions, IRR calculation methodology, and vintage year applicability.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
29
The slide presents a breakdown of assets by segment (Asset Management and Retirement Services) with specific line items for cash, investments, and other assets.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
30
Financial data table showing liabilities and equity components.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
31
Includes detailed footnotes explaining specific adjustments like equity-based profit sharing and non-operating changes in insurance liabilities.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
32
Includes footnotes explaining specific adjustments like equity-based compensation and merger-related costs.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
33
Includes footnotes regarding adjustments for consolidated funds, VIEs, and profit sharing arrangements.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
34
The table provides a detailed breakdown of adjustments including investment gains/losses, non-operating changes, and stock compensation.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
35
The slide contains two distinct sub-tables for different asset categories.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
36
Standard financial disclosure slide defining non-GAAP metrics.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
37
This is a standard financial definitions page found in investor presentations.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
38
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
39
This is a standard disclosure/definitions slide common in financial investor presentations.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
40
This is a standard appendix slide providing technical definitions and endnote clarifications for a financial presentation.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
41
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
03
The slide outlines the core therapeutic strategy of Arbutus Biopharma.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
04
The slide uses a column-based layout to present key value propositions.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a four-column layout to structure the disease overview.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem1 hit
07
Uses a geographic map and a nested circle diagram to illustrate the treatment gap.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
10
The slide highlights the mechanism of action and key therapeutic benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
11
The slide outlines the study design for cohorts E through K in Part 3 of the trial.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
12
Data shows consistent efficacy across different patient subgroups.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
13
The slide displays longitudinal clinical trial data for a drug candidate (Imdusiran) across various dosing regimens (Cohorts E, F, I, J, G, K).Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
14
Clinical trial data showing individual patient responses over time, including two cases of NA retreatment.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
16
The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and stability of laboratory markers.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
17
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
18
The slide uses a timeline-based process diagram to illustrate the clinical trial randomization and treatment arms.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
19
Shows two parallel trial arms with timelines and patient counts.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
20
The slide details the financial terms of the deal and the scope of the partnership.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
21
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
24
The slide includes a financial summary at the top and a list of clinical trial milestones with completion checkmarks.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · The Ask1 hit
25
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · The Ask1 hit
01
Slide 1
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
02
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
03
The slide uses a circular process flow diagram to illustrate the company's growth strategy.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
04
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
05
The slide uses a timeline-based clinical trial design framework.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide outlines a randomized clinical trial structure.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide uses a list format to communicate a roadmap of clinical milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
08
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
09
The slide uses a 2D matrix-like structure to show expansion vectors.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
10
The slide uses a central circular image overlaying a four-quadrant layout of strategic pillars.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key TakeawaysLoop · Quick Win Big Bet1 hit
11
The slide uses a chronological progression (Today vs Future) to outline product development milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
12
The map uses teal dots for VYVGART and a purple dot for VYVGART Hytrulo, though the legend is implicit in the side tables.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
13
The slide combines corporate messaging with a personal patient story to humanize the clinical data.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
14
The slide uses a hub-and-spoke visual metaphor to represent corporate values.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
01
Slide 1
Aston Martin Lagonda | Results Presentation Deck | 18 slidesAston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Attention1 hit
02
Includes financial metrics (revenue, profit, EBITDA, liquidity, debt) and operational updates (product launches, financing, partnerships).Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Attention1 hit
03
Includes a decorative abstract image on the right side.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
04
The slide uses a donut chart for volume distribution and a stacked bar chart for ASP comparison.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
05
The slide uses a map-based visualization to show regional performance, with callout bubbles for percentage change and bar charts for absolute volume.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit